Tune Therapeutics: New Startup Co-founded by Gersbach Launches with Pioneering Epigenomic Control Platform to Master Gene Networks, Treat Broad Range of Diseases

Tune Thereapeutics logo
GCB News

Tune Therapeutics: New Startup Co-founded by Gersbach Launches with Pioneering Epigenomic Control Platform to Master Gene Networks, Treat Broad Range of Diseases

World-leading researchers and venture-builders found company to mine the new frontier of epigenomics and unlock complex disease

Novel approach tunes and calibrates gene expression without breaking or rewriting DNA

Unique TEMPO platform targets complex gene networks, reveals the underlying, epigenomic drivers of disease, and yields optimized therapeutic candidates that shift cell state and function

Read the press release at Tune Therapeutics